J. William Efcavitch

Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA.

M2Gen Corp. provides informatics-based solutions to accelerate the discovery, development, and delivery of personalized medicine. Its solutions include Total Cancer Care Protocol and ORIEN Avatar. The company was founded by William S. Dalton in 2006 and is headquartered in Tampa, FL.

Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA.

iXCells Biotechnologies USA LLC is a cell biology and cell technology company that provides high-quality primary cells, normal and diseased iPS cell lines, iPSC-derived cell products, custom iPSC services, and functional bioassay development and execution. iXCells Biotechnologies USA is based in San Diego, CA. The company offers cost-effective pluripotent stem cells (iPSC) differentiation services with fast turnaround time for research purposes. The company was founded in 2014 by Nianwei Lin.

Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany.

Paranetics, Inc. revolutionizes electric motor design for the aircraft and automotive industry with their ParaNetics Magnetic Technology. The company is based in San Diego, CA. The company's technology allows for a new generation of electronically controlled valves to be manufactured, which are used in applications where precise control and durability are essential, such as infusion pumps and high repetition cycling applications.

Kalos Therapeutics, Inc. provides biopharmaceutical product development services. The company develops and commercializes products for the treatment of cancers and related co-morbidities. The company was founded by George Colberg and is headquartered in Phoenix, AZ.

Rubicon Venture Capital LLC (Rubicon Venture Capital) is a venture capital firm founded in 2013. The firm is headquartered in San Francisco, California.

Part of Becton, Dickinson & Co., PreAnalytiX GmbH is a Swiss company that specializes in developing paxgene products for the collection, transport, storage, stabilization, and purification of nucleic acids from human specimens. The company is based in Hombrechtikon, Switzerland. The company aims to improve diagnosis, treatment, and monitoring of diseases by providing biospecimens of the highest quality.

Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA.

Alexandria Venture Investments LLC (Alexandria Venture) is a venture capital subsidiary of Alexandria Real Estate Equities, Inc. founded in 1996 by Joel S. Marcus. The firm is headquartered in Pasadena, California.

Eclipse Bioinnovations, Inc. is a private biotechnology company that develops first-in-class technologies to accelerate the development of RNA genomics discoveries and medicines. The company is based in San Diego, CA. The company offers its end-to-end RNA genomics products as services and kits and also provides custom RNA genomics services for select partners. Laboratory at UC San Diego. Eclipse Bio is an RNA next-generation sequencing (NGS) company founded in 2017 based on technologies and algorithms developed in Dr. The company was founded by Alexander Shishkin, Peter Chu, and Eugene W. Yeo. Peter Chu has been the CEO since incorporation.

NanoCellect Biomedical, Inc. develops flow cytometry and cell sorting technology solutions for life science researchers to perform cellular analysis, develop molecular diagnostics, and improve personalized medicine. Its products include wolf cell sorter and N1 single cell dispenser. The company was founded by Nate Heintzman and Yuhwa Lo in 2009 and is headquartered in San Diego, CA.

The Allen Institute, specifically the Paul G. Allen Frontiers Group, is dedicated to exploring the field of bioscience to identify and foster ideas that have the potential to change the world. The non-profit company is based in Seattle, WA and has subsidiaries in the United States. The group recommends funding to the Paul G. Allen Family Foundation, which invests in award mechanisms to accelerate the understanding of biology. This includes the Allen Discovery Centers at partner institutions for leadership-driven, compass-guided research, and Allen Distinguished Investigators for frontier explorations with exceptional creativity and potential impact.

The Keck School of Medicine of USC is a place of dynamic activity in patient care, scientific discovery, medical and bioscience education, and community service. Their faculty, staff, students, residents, alumni, donors and friends are committed to excellence. Together they are poised to lead medicine in the 21st Century for the benefit of humankind. This is an exciting time of great transformation as they endeavor to create a truly stellar academic medical center at USC.

Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA.

Corporate Directors Forum operates as a forum for corporate directors. The non-profit company is based in La Jolla, CA.

Part of Scientific Industries, Inc., Scientific Bioprocessing, Inc. (SBI) offers solutions for digitally simplified bioprocessing in the life science industry. The company is based in Pittsburgh, PA. SBI's DOTS platform turns the standard shake flask into a smart mini bioreactor by providing modern bioprocessing sensors and control options along with innovative software for easy sensor control and data monitoring. The company was founded by Govind Rao, Joe Qualitz. Daniel Grünes has been the CEO of the company since 2021.

Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA.

VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA.

Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.